Repertorial approach of treating non-alcoholic fatty liver disease in adults using individualized homoeopathic medicines: A single-arm, pre-post trial

D N De Homoeopathic Medical College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年4月3日

试验速览

暂无简介。

•1. Patient with grade I and II NAFLD established by ultrasound and altered liver enzyme (serum ALT level >=40 IU/L) [ICD-10 code: K 76.0].
•2. Age between 18 and 65 years.
•3. Participants of either sex and transgender.
•4. Literate patients; ability to read English and/or Bengali and/or Hindi; Illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the questionnaires.
•5. Providing with written informed consent voluntarily to participate.

•1. Regular or excessive use of alcohol and any other addiction.
•2. History of chronic liver disease (Viral hepatitis B or C, autoimmune hepatitis).
•3. Cholestatic and metabolic liver diseases, hepatic steatosis., hemochromatosis and liver transplants.
•4. Combined with uncontrolled diabetes, uncontrolled hypertension, uncontrolled hypothyroidism, kidney or heart disease, stroke or any other severe systemic diseases affecting quality of life.
•5. Person under corticosteroid therapy, substance abuse.
•6. Vulnerable population â?? unconscious, non-ambulatory, too sick for consultation, differently abled, terminally ill or critically ill, mentally incompetent people.
•7. Pregnant and puerperal women and lactating mother.
•8. Self-reported immune-compromised state.
•9. Already undergoing homoeopathic treatment within last 3 months for any other disease.
•10. Simultaneous participation in any other trials.

发起方

D N De Homoeopathic Medical College and Hospital